Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 708-716

  Bednarek, Paula H ^a   Lee, Betty J ^a   Gandhi, Sanjay ^a   Lee, Edward ^a   Phillips, Benette ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DNA FOOTPRINTING; ENHANCER REGION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS TRANSCRIPTION; WART VIRUS;

EID: 0031984989     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.708-716.1998     Document Type: Article

References (56)

1. Bauknecht, T., P. Angel, H.-D. Royer, and H. zur Hausen. 1992. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J. 11:4607-4617.
2. Bauknecht, T., F. Jundt, I. Herr, T. Oehler, H. Delius, Y. Shi, P. Angel, and H. zur Hausen. 1995. A switch region determines the cell-type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter. J. Virol. 69:1-12.
3. Bauknecht, T., R. H. See, and Y. Shi. 1996. A novel CIEBP B-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J. Virol. 70:7695-7705.
4. Becker, P. B., and G. Schutz. 1988. Genomic footprinting, p. 1-19. In J. K. Setlow (ed.), Genetic engineering, principles and methods, vol. 10. Plenum Press, New York, N.Y.
5. Berumen, J., E. R. Unger, L. Casas, and P. Figueroa. 1995. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum. Pathol. 26:676-681.
6. Butz, K., and F. Hoppe-Seyler. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67:6476-6486.
7. Chong, T., W.-K. Chan, and H.-U. Bernard. 1990. Transcriptional activation of human papillomavirus 16 by nuclear factor 1, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res. 18:465-470.
8. Chong, T., D. Apt, B. Gloss, M. Isa, and H.-U. Bernard. 1991. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors Oct-1, NFA, TEF-2, NF1, and AP1 participate in epithelial cell-specific transcription. J. Virol. 65:5933-5943.
9. Cole, S. T., and O. Danos. 1987. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. J. Mol. Biol. 193:599-608.
10. Cripe, T. M., T. H. Haugen, J. P. Turk, F. Tabatabai, P. G. Schmid III, M. Durst, L. Gissman, A. Roman, and L. B. Turek. 1987. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 6:3745-3753.
11. Cullen, A. P., R. Reid, M. Campion, and A. T. Lorincz. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
12. Davidson, I., J. H. Xiao, R. Rosales, A. Staub, and P. Chambron. 1988. The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequences. Cell 54:931-942.
13. El Awady, M. K., J. B. Kaplan, S. J. O'Brien, and R. D. Burk. 1987. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159:389-398.
14. Garcia-Carranca, A., F. Thierry, and M. Yaniv. 1988. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J. Virol. 62:4321-4330.
15. Garrity, P. A., D. Chen, E. V. Rothenberg, and B. J. Wold. 1994. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 14:2159-2169.
16. Gloss, B., H. U. Bernard, K. Seedorf, and G. Klock. 1987. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6:3735-3743.
17. Gloss, B., M. Yeo-Gloss, M. Meisterernst, L. Rogge, E. L. Winnacker, and H.-U. Bernard. 1989. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res. 17:3519-3533.
18. Gorzowski, J. J., C. A. Eckerley, R. G. Halgren, A. B. Mangurten, and B. Phillips. 1995. Methylation-associated transcriptional silencing of the MHC-linked hsp70 genes in mouse cell lines. J. Biol. Chem. 270:26940-26949.
19. Heck, D. V., C. L. Yee, P. M. Howley, and K. Munger. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89:4442-4446.
20. Hoppe-Seyler, F., K. Butz, and H. zur Hausen. 1991. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol. 65:5613-5618.
21. Hoppe-Seyler, F., and K. Butz. 1992. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor SpI. Nucleic Acids Res. 20:6701-6706.
22. Hoppe-Seyler, F., and K. Butz. 1994. Cellular control of human papillomavirus oncogene transcription. Mol. Carcinog. 10:134-141.
23. Hornstra, I. K., and T. P. Yang. 1993. In vivo footprinting and genomic sequencing by ligation-mediated PCR. Anal. Biochem. 213:179-193.
24. Ishiji, T., M. J. Lace, S. Parkkinen, R. D. Anderson, T. H. Haugen, T. P. Cripe, J. H. Xiao, I. Davidson, P. Chambron, and L. P. Turek. 1992. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J. 11:2271-2281.
25. Jacquemin, P., J. J. Hwang, J. A. Martial, P. Dolle, and I. Davidson. 1996. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J. Biol. Chem. 271:21775-21785.
26. Jeon, S., and P. F. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
27. Kaur, P., J. K. McDougall, and R. Cone. 1989. Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. J. Gen. Virol. 70:1261-1266.
28. Liu, Z., J. Ghai, R. S. Ostrow, and A. J. Faras. 1995. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Virology 207:260-270.
29. Mack, D. H., and L. A. Laimins. A keratinocyte-specific transcription factor, KRF-1 interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc. Natl. Acad. Sci. USA 88:9102-9106.
30. McGhee, J. D., and G. Felsenfeld. 1979. Reaction of nucleosome DNA with dimethyl sulfate. Proc. Natl. Acad. Sci. USA 76:2133-2137.
31. Medina-Martinez, O., N. Morales-Peza, M. Yaniv, A. Garcia-Carranca, and F. Thierry. 1996. A single element mediates glucocorticoid hormone response of HPV18 with no functional interactions with AP1 or hbrm. Virology 217:392-396.
32. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780-785.
33. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
34. Murphy, S. P., J. J. Gorzowski, K. D. Sarge, and B. Phillips. 1994. Characterization of constitutive HSF2 DNA binding activity in mouse embryonal carcinoma cells. Mol. Cell. Biol. 14:5309-5317.
35. Nakshatri, H., M. M. Pater, and A. Pater. 1990. Ubiquitous and cell-type-specific protein interactions with human papillomavirus type 16 and type 18 enhancers. Virology 178:92-103.
36. O'Connor, M., and H.-U. Bernard. 1995. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NF1 at a conserved composite regulatory element. Virology 207: 77-88.
37. Pfeifer, G. P., R. L. Tanguay, S. D. Steigerwald, and A. D. Riggs. 1990. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at CpG island and promoter of human PGK-1. Genes Dev. 4:1277-1287.
38. Remm, M., R. Brain, and J. R. Jenkins. 1992. The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res. 20:6015-6021.
39. Romanczuk, H., L. L. Villa, R. Schlegel, and P. M. Howley. 1991. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 65:2739-2744.
40. Saluz, H. P., and J. P. Jost. 1993. Approaches to characterize protein-DNA interactions in vivo. Crit. Rev. Eukaryotic Gene Expression 3:1-29.
41. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
42. Schneider-Gadicke, A., and E. Schwarz. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
43. Schrock, A., and B. Phillips. Unpublished data.
44. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114
45. Stoler, M. H., C. R. Rhodes, A. Whitbeck, S. M. Wolinsky, L. T. Chow, and T. R. Broker. 1992. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23:117-128.
46. Swift, F. V., K. Bhat, H. B. Younghusband, and H. Hamada. 1987. Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome. EMBO J. 6:1339-1344.
47. Thierry, F., A. Garcia-Carranca, and M. Yaniv. 1987. Elements that control the transcription of genital papillomavirus type 18. Cancer Cells 5:23-32.
48. Thierry, F., J. M. Heard, and M. Yaniv. 1987. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J. Virol. 61: 134-142.
49. Thierry, F., G. Spyrou, M. Yaniv, and P. Howley. 1992. Two AP1 sites binding junB are essential for human papillomavirus type 18 transcription in keratinocytes. J. Virol. 66:3740-3748.
50. Tommasi, S., and G. P. Pfeifer. 1995. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15:6901-6913.
51. Turek, L. P. 1994. The structure, function, and regulation of papillomavirus genes in infection and cervical cancer. Adv. Virus Res. 44:305-356.
52. von Knebel Doeberitz, M., T. Oltersdorf, E. Schwartz, and L. Gissmaan. 1988. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 48:3780-3786.
53. von Knebel Doeberitz, M., T. Bauknecht, D. Bartsch, and H. zur Hausen. 1991. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 88:1411-1415.
54. von Knebel Doeberitz, M., C. Rittmuller, F. Aengeneyndt, P. Jansen-Durr, and D. Spitkovsky. 1994. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J. Virol. 68:2811-2821.
55. Xiao, J. H., I. Davidson, H. Matthes, J. M. Garnier, and P. Chambon. 1991. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551-568.
56. zur Hausen, H. 1991. Human papillomavirus in the pathogenesis of anogenital cancer. Virology 184:9-13.